181 related articles for article (PubMed ID: 19436268)
1. Heat shock protein 27 as a new therapeutic target for radiation sensitization of head and neck squamous cell carcinoma.
Hadchity E; Aloy MT; Paulin C; Armandy E; Watkin E; Rousson R; Gleave M; Chapet O; Rodriguez-Lafrasse C
Mol Ther; 2009 Aug; 17(8):1387-94. PubMed ID: 19436268
[TBL] [Abstract][Full Text] [Related]
2. Protective role of Hsp27 protein against gamma radiation-induced apoptosis and radiosensitization effects of Hsp27 gene silencing in different human tumor cells.
Aloy MT; Hadchity E; Bionda C; Diaz-Latoud C; Claude L; Rousson R; Arrigo AP; Rodriguez-Lafrasse C
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):543-53. PubMed ID: 17980509
[TBL] [Abstract][Full Text] [Related]
3. OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer.
Baylot V; Andrieu C; Katsogiannou M; Taieb D; Garcia S; Giusiano S; Acunzo J; Iovanna J; Gleave M; Garrido C; Rocchi P
Cell Death Dis; 2011 Oct; 2(10):e221. PubMed ID: 22012255
[TBL] [Abstract][Full Text] [Related]
4. Hsp27 Inhibition with OGX-427 Sensitizes Non-Small Cell Lung Cancer Cells to Erlotinib and Chemotherapy.
Lelj-Garolla B; Kumano M; Beraldi E; Nappi L; Rocchi P; Ionescu DN; Fazli L; Zoubeidi A; Gleave ME
Mol Cancer Ther; 2015 May; 14(5):1107-16. PubMed ID: 25740245
[TBL] [Abstract][Full Text] [Related]
5. HIV Protease Inhibitors Sensitize Human Head and Neck Squamous Carcinoma Cells to Radiation by Activating Endoplasmic Reticulum Stress.
Liu R; Zhang L; Yang J; Zhang X; Mikkelsen R; Song S; Zhou H
PLoS One; 2015; 10(5):e0125928. PubMed ID: 25933118
[TBL] [Abstract][Full Text] [Related]
6. Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells.
Kamada M; So A; Muramaki M; Rocchi P; Beraldi E; Gleave M
Mol Cancer Ther; 2007 Jan; 6(1):299-308. PubMed ID: 17218637
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Hsp27 radiosensitizes head-and-neck cancer by modulating deoxyribonucleic acid repair.
Guttmann DM; Hart L; Du K; Seletsky A; Koumenis C
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):168-75. PubMed ID: 23849696
[TBL] [Abstract][Full Text] [Related]
8. Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma.
Ekshyyan O; Rong Y; Rong X; Pattani KM; Abreo F; Caldito G; Chang JK; Ampil F; Glass J; Nathan CO
Mol Cancer Ther; 2009 Aug; 8(8):2255-65. PubMed ID: 19625495
[TBL] [Abstract][Full Text] [Related]
9. Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer.
Hadaschik BA; Jackson J; Fazli L; Zoubeidi A; Burt HM; Gleave ME; So AI
BJU Int; 2008 Aug; 102(5):610-6. PubMed ID: 18384625
[TBL] [Abstract][Full Text] [Related]
10. Targeting of tumor endothelial cells combining 2 Gy/day of X-ray with Everolimus is the effective modality for overcoming clinically relevant radioresistant tumors.
Kuwahara Y; Mori M; Kitahara S; Fukumoto M; Ezaki T; Mori S; Echigo S; Ohkubo Y; Fukumoto M
Cancer Med; 2014 Apr; 3(2):310-21. PubMed ID: 24464839
[TBL] [Abstract][Full Text] [Related]
11. Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.
Macha MA; Rachagani S; Qazi AK; Jahan R; Gupta S; Patel A; Seshacharyulu P; Lin C; Li S; Wang S; Verma V; Kishida S; Kishida M; Nakamura N; Kibe T; Lydiatt WM; Smith RB; Ganti AK; Jones DT; Batra SK; Jain M
Oncotarget; 2017 Mar; 8(13):20961-20973. PubMed ID: 28423495
[TBL] [Abstract][Full Text] [Related]
12. Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer.
Zerp SF; Stoter TR; Hoebers FJ; van den Brekel MW; Dubbelman R; Kuipers GK; Lafleur MV; Slotman BJ; Verheij M
Radiat Oncol; 2015 Jul; 10():158. PubMed ID: 26223311
[TBL] [Abstract][Full Text] [Related]
13. Combining ultrasmall gadolinium-based nanoparticles with photon irradiation overcomes radioresistance of head and neck squamous cell carcinoma.
Miladi I; Aloy MT; Armandy E; Mowat P; Kryza D; Magné N; Tillement O; Lux F; Billotey C; Janier M; Rodriguez-Lafrasse C
Nanomedicine; 2015 Jan; 11(1):247-57. PubMed ID: 24983891
[TBL] [Abstract][Full Text] [Related]
14. LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma.
Yang L; Kumar B; Shen C; Zhao S; Blakaj D; Li T; Romito M; Teknos TN; Williams TM
Mol Cancer Ther; 2019 Jun; 18(6):1025-1035. PubMed ID: 31015310
[TBL] [Abstract][Full Text] [Related]
15. BIIB021, a novel Hsp90 inhibitor, sensitizes head and neck squamous cell carcinoma to radiotherapy.
Yin X; Zhang H; Lundgren K; Wilson L; Burrows F; Shores CG
Int J Cancer; 2010 Mar; 126(5):1216-25. PubMed ID: 19662650
[TBL] [Abstract][Full Text] [Related]
16. Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts.
Vink SR; Lagerwerf S; Mesman E; Schellens JH; Begg AC; van Blitterswijk WJ; Verheij M
Clin Cancer Res; 2006 Mar; 12(5):1615-22. PubMed ID: 16533789
[TBL] [Abstract][Full Text] [Related]
17. Combined radiation sensitizing and anti-angiogenic effects of ionizing radiation and the protease inhibitor ritonavir in a head and neck carcinoma model.
Maggiorella L; Wen B; Frascogna V; Opolon P; Bourhis J; Deutsch E
Anticancer Res; 2005; 25(6B):4357-62. PubMed ID: 16309240
[TBL] [Abstract][Full Text] [Related]
18. Antitumor mechanisms of systemically administered epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck.
Thomas SM; Ogagan MJ; Freilino ML; Strychor S; Walsh DR; Gooding WE; Grandis JR; Zamboni WC
Mol Pharmacol; 2008 Mar; 73(3):627-38. PubMed ID: 18025070
[TBL] [Abstract][Full Text] [Related]
19. A comparison of cell survival and heat shock protein expression after radiation in normal dermal fibroblasts, microvascular endothelial cells, and different head and neck squamous carcinoma cell lines.
Muschter D; Geyer F; Bauer R; Ettl T; Schreml S; Haubner F
Clin Oral Investig; 2018 Jul; 22(6):2251-2262. PubMed ID: 29307045
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of enzastaurin as radiation sensitizer in head and neck squamous cell carcinoma.
Yin X; Hayes DN; Shores CG
Head Neck; 2011 Aug; 33(8):1106-14. PubMed ID: 20967867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
